Loading stock data…
$8.27-0.15 (-1.84%)
OptimizeRx Corporation operates as a digital healthcare technology company.
OptimizeRx Corporation in the Healthcare sector is trading at $8.27 with a market capitalization of $145M. Wall Street consensus targets $12.60 (5 analysts), implying a +52.4% move over the next 12 months. The stock is currently 63% below its 52-week high of $22.25, remaining 9.8% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $20.50M↑ | $19.84M↓ | $32.24M↑ | $26.07M↓ | $29.20M |
| Gross Profit | $15.69M↑ | $14.93M↓ | $24.10M↑ | $17.52M↓ | $18.64M |
| Operating Income | -$88,000↓ | $396,000↓ | $8.94M↑ | $2.05M↓ | $3.21M |
| Net Income | -$703,000↓ | -$495,000↓ | $5.02M↑ | $779,000↓ | $1.53M |
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, wh...